{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:40Z","timestamp":1786982200252,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Basic and Applied Basic Research Fund of Guangdong Province","award":["2020A1515110485"],"award-info":[{"award-number":["2020A1515110485"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81201919"],"award-info":[{"award-number":["81201919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100017440","name":"National Natural Science Foundation of China-Shenzhen Robotics Research Center Project","doi-asserted-by":"publisher","award":["U1813204"],"award-info":[{"award-number":["U1813204"]}],"id":[{"id":"10.13039\/100017440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Natural Science Foundation of Guangdong Province","award":["2017A030313495"],"award-info":[{"award-number":["2017A030313495"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12029-024-01023-9","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:01:56Z","timestamp":1706313716000},"page":"800-808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High Bile Titer and High Bile to Serum Ratio of CYFRA 21\u2009\u2212\u20091 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma"],"prefix":"10.1007","volume":"55","author":[{"given":"Jiancong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongcong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"issue":"2","key":"1023_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol. 2018;15(2):95\u2013111.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"1023_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"1023_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1148\/radiol.2018171187","volume":"288","author":"I Joo","year":"2018","unstructured":"Joo I, Lee JM, Yoon JH. Imaging diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: recent advances and challenges. Radiology. 2018;288(1):7\u201313.","journal-title":"Radiology"},{"issue":"Suppl 1","key":"1023_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/liv.14090","volume":"39","author":"RIR Macias","year":"2019","unstructured":"Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, et al. Diagnostic and prognostic biomarkers in cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):108\u201322.","journal-title":"Liver Int"},{"issue":"3","key":"1023_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/hep.28493","volume":"64","author":"N-O Ku","year":"2016","unstructured":"Ku N-O, Strnad P, Bantel H, Bishr Omary M. Keratins: biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology. 2016;64(3):966\u201376.","journal-title":"Hepatology"},{"key":"1023_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0009-9120(93)90129-T","volume":"26","author":"P Stieber","year":"1993","unstructured":"Stieber P, Bodenm\u00fcller H, Banauch D, Hasholzner U, Dessauer A, Ofenloch-H\u00e4hnle B, et al. Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer. Clin Biochem. 1993;26:301\u20134.","journal-title":"Clin Biochem"},{"key":"1023_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0959-8049(94)90528-2","volume":"30A","author":"D Rastel","year":"1994","unstructured":"Rastel D, Ramaioli A, Cornillie F, Thirion B. CYFRA 21\u2009\u2013\u20091, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21\u2009\u2013\u20091 Multicentre Study Group. Eur J Cancer. 1994;30A:601\u20136.","journal-title":"Eur J Cancer"},{"key":"1023_CR8","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1245\/s10434-007-9650-y","volume":"15","author":"T Uenishi","year":"2008","unstructured":"Uenishi T, Yamazaki O, Tanaka H, Takemura S, Yamamoto T, Tanaka S, et al. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15:583\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1023_CR9","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s10620-014-3472-0","volume":"60","author":"L Huang","year":"2015","unstructured":"Huang L, Chen W, Liang P, Hu W, Zhang K, Shen S, et al. Serum CYFRA 21\u2009\u2013\u20091 in biliary tract cancers: a Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma. Dig Dis Sci. 2015;60:1273\u201383.","journal-title":"Dig Dis Sci"},{"key":"1023_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0973-6883(11)60110-2","volume":"1","author":"MH Chapman","year":"2011","unstructured":"Chapman MH, Sandanayake NS, Andreola F, Dhar DK, Webster GJ, Dooley JS, et al. Circulating CYFRA 21\u2009\u2013\u20091 is a specific diagnostic and prognostic biomarker in biliary Tract Cancer. J Clin Exp Hepatol. 2011;1:6\u201312.","journal-title":"J Clin Exp Hepatol"},{"key":"1023_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hep.30319","volume":"70","author":"JM Banales","year":"2019","unstructured":"Banales JM, I\u00f1arrairaegui M, Arbelaiz A, Milkiewicz P, Muntan\u00e9 J, Mu\u00f1oz-Bellvis L, et al. Serum metabolites as diagnostic biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and primary sclerosing Cholangitis. Hepatology. 2019;70:547\u201362.","journal-title":"Hepatology"},{"key":"1023_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MOG.0b013e328325a894","volume":"25","author":"D Alvaro","year":"2009","unstructured":"Alvaro D. Serum and bile biomarker for cholangiocarcinoma. Curr Opin Gastroenterol. 2009;25:279\u201384.","journal-title":"Curr Opin Gastroenterol"},{"issue":"7","key":"1023_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41395-018-0122-8","volume":"113","author":"WH Paik","year":"2018","unstructured":"Paik WH, Lee TH, Park DH, Choi JH, Kim SO, Jang S, et al. EUS-Guided biliary drainage Versus ERCP for the primary palliation of malignant biliary obstruction: a Multicenter Randomized Clinical Trial. Am J Gastroenterol. 2018;113(7):987\u201397.","journal-title":"Am J Gastroenterol"},{"key":"1023_CR14","first-page":"6663","volume":"34","author":"F Lumachi","year":"2014","unstructured":"Lumachi F, Lo Re G, Tozzoli R, D\u2019Aurizio F, Facomer F, Chiara GB, et al. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19\u2009\u2013\u20099, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study. Anticancer Res. 2014;34:6663\u20137.","journal-title":"Anticancer Res"},{"key":"1023_CR15","first-page":"616","volume":"49","author":"CY Chen","year":"2002","unstructured":"Chen CY, Shiesh SC, Tsao HC, Lin XZ. The assessment of biliary CA 125, CA 19\u2009\u2013\u20099 and CEA in diagnosing cholangiocarcinoma\u2013the influence of sampling time and hepatolithiasis. Hepatogastroenterology. 2002;49:616\u201320.","journal-title":"Hepatogastroenterology"},{"issue":"10272","key":"1023_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX. Biliary tract cancer. Lancet. 2021;397(10272):428\u201344.","journal-title":"Lancet"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-024-01023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-024-01023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T21:07:38Z","timestamp":1718831258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-024-01023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1007\/s12029-024-01023-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3262912\/v1","asserted-by":"object"}]},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]},"assertion":[{"value":"23 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}